ArticleESMO open2020

Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study.

Virve Alanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.